Kevin K. Buckbee was appointed as Senior Vice President, Controller at AbbVie Inc..
“Kevin K. Buckbee, 57, has been appointed Senior Vice President, Controller effective March 1, 2023.”
AbbVie Inc. — fact timeline
Source-grounded facts extracted from AbbVie Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Brian L. Durkin departed as Vice President, Controller at AbbVie Inc..
“On November 28, 2022, Brian L. Durkin, Vice President, Controller, informed AbbVie that he plans to retire from the Controller role effective March 1, 2023.”
Scott T. Reents was appointed as Executive Vice President, Chief Financial Officer at AbbVie Inc..
“Scott T. Reents, Senior Vice President, Chief Financial Officer, has been appointed Executive Vice President, Chief Financial Officer, effective immediately.”
AbbVie Inc. reported the third quarter ended September 30, 2022 results: revenue $14.812 Billion, EPS $3.66. Guidance reaffirmed.
“• Reports Third-Quarter Diluted EPS of $2.21 on a GAAP Basis, an Increase of 24.2 Percent; Adjusted Diluted EPS of $3.66, an Increase of 29.3 Percent; These Results Include an Unfavorable Impact of $0.02 Per Share related to Acquired IPR&D and Milestones Expense 1 • Delivers Third-Quarter Net Revenues of $14.812 Billion, an Increase of 3.3 Percent on a Reported Basis and 5.4 Percent Operationally”
Laura J. Schumacher departed as Vice Chairman, External Affairs and Chief Legal Officer at AbbVie Inc..
“Laura J. Schumacher, Vice Chairman, External Affairs and Chief Legal Officer, informed AbbVie that she plans to retire from the company after a period of transition.”
Scott T. Reents was appointed as Senior Vice President, Chief Financial Officer at AbbVie Inc..
“Scott T. Reents, 55, has been appointed Senior Vice President, Chief Financial Officer, effective June 23, 2022.”
Robert A. Michael was appointed as Vice Chairman and President at AbbVie Inc..
“Robert A. Michael, 51, has been appointed Vice Chairman and President, effective June 23, 2022.”
Michael E. Severino departed as Vice Chairman and President at AbbVie Inc..
“On April 8, 2022, Michael E Severino informed AbbVie that he will be departing as AbbVie’s Vice Chairman and President, effective May 31, 2022.”
Edward M. Liddy retired as director at AbbVie Inc..
“Edward M. Liddy informed AbbVie Inc. of his decision to retire as a director as of the 2022 annual shareholders meeting in May.”
Robert A. Michael was appointed as Vice Chairman, Finance and Commercial Operations and Chief Financial Officer at AbbVie Inc..
“Robert A. Michael, 51, has been appointed Vice Chairman, Finance and Commercial Operations and Chief Financial Officer, effective as of December 16, 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.